FDA Rejection Of Avastin For Breast Cancer Therapy Would Be 'Unscientific, Unethical,' Editorial Says
FDA respingere de Avastin pentru cancerul de sân terapie ar fi "neºtiinþific, fãrã scrupule," spune Editorial - FDA Rejection Of Avastin For Breast Cancer Therapy Would Be 'Unscientific, Unethical,' Editorial Says - articole medicale engleza - startsanatate